To: saukriver who wrote (35042 ) 11/19/2000 4:43:30 PM From: techreports Read Replies (1) | Respond to substancep, from what i've read on HGSI, they've been working on finding proteins that have to do with diseases since the early 90s. They can't possibly make all the drugs that they've received or going to received patents on. Therefor, they give the crappier patents to other companies and just get pure royalties. HGSI plans to have it's first drug out by 2002 or 2003. These drugs should have a high probability of getting approved by the FAA or whatever organization approves drugs b/c HGSI's drugs are natural substances found in the human body. Anyone who sells a drug that uses one of HGSI's possible 7,700 patents will pay royalties." is a big stretch. hgsi.com founded in 1992, is a pioneer in the use of genomics, the study of all human genes, and the development of new pharmaceutical products. We are a leader in moving these genomics-based drugs into patient-based clinical trials. In 1999, three HGS drugs were tested in patients. Our goal is to become a global biopharmaceutical company that discovers, develops, manufactures and sells our own genomics-based drugs .
